MERIDIAN BIOSCIENCE INC (VIVO) Stock Analyst Ratings
USA - NASDAQ:VIVO - US5895841014 - Common Stock
33.97 USD
0 (0%)
33.99 USD
+0.02 (+0.06%)
ChartMill assigns a Buy % Consensus number of 43% to VIVO. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 34.68. This target is 2.09% above the current price.
VIVO was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about VIVO.
In the previous month the buy percentage consensus was at a similar level.
VIVO was analyzed by 6 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-07-08 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2022-02-07 | HC Wainwright & Co. | Maintains | Buy |
| 2021-11-15 | HC Wainwright & Co. | Maintains | Buy |
| 2021-08-09 | HC Wainwright & Co. | Maintains | Buy |
| 2021-05-10 | HC Wainwright & Co. | Maintains | Buy |
| 2021-02-24 | HC Wainwright & Co. | Maintains | Buy |
| 2021-02-08 | HC Wainwright & Co. | Maintains | Buy |
MERIDIAN BIOSCIENCE INC / VIVO FAQ
What do analysts expect the price target to be for MERIDIAN BIOSCIENCE INC (VIVO)?
6 analysts have analysed VIVO and the average price target is 34.68 USD. This implies a price increase of 2.09% is expected in the next year compared to the current price of 33.97.
What is the consensus rating for VIVO stock?
The consensus rating for MERIDIAN BIOSCIENCE INC (VIVO) is 43.3333 / 100 . This indicates that analysts generally have a neutral outlook on the stock.
How many analysts cover MERIDIAN BIOSCIENCE INC (VIVO) stock?
The number of analysts covering MERIDIAN BIOSCIENCE INC (VIVO) is 6.